Weighing the clinical significance of new clinical trial results with immunotherapy in stage III and IV NSCLC

West Wind (Audio)

English - April 09, 2019 11:00 - 19 minutes - 29.8 MB - ★★★★★ - 18 ratings
Science Health & Fitness Medicine cancer oncology health science medicine education howard jack west westwind Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Dr. Gil Morgan (Part 2): Overcoming Barriers in Cancer Care Delivery, Smoking Cessation, & Lung Cancer Screening Globally

Next Episode: Dr. Jed Gorden (Part 1): Rolling Out Chest CT Screening and Pulmonary Workups into the Real World Beyond Tertiary Care Centers

Drs. Jack West & Corey Langer debate the criteria for adopting early clinical data as practice-changing as immunotherapy trials in locally advanced & metastatic NSCLC are reported.